VR in Neurosurgery: Planning, Training & Communication
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Aug 19, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Virtual Reality Patient Consent in Neurosurgery," is exploring how using virtual reality (VR) technology can help patients better understand the information they need before having brain surgery. The study is comparing the traditional way of explaining surgery to patients with a new approach that uses VR. Researchers want to see if the VR method makes patients feel more comfortable and informed about their surgery, helps them connect better with their doctors, and reduces any anxiety they might have.
To participate in this trial, you should be between 65 and 74 years old, able to give consent (or have a legal representative do so), and have a brain condition that can be seen on a preoperative scan. If you join, you can expect to engage with both the standard consent process and the VR experience, allowing you to share your thoughts and feelings about each method through questionnaires. This study is currently recruiting participants and aims to improve the way patients receive important information about their surgical options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient is able to give written consent (or written consent by legal representative)
- • Preoperative imaging demonstrating intracranial pathology
- • Cognitively able to provide answers for the questionnaires
- Exclusion Criteria:
- • No informed consent
- • Adult patients without the power of judgement
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Attill Saemann, MD
Principal Investigator
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported